128 related articles for article (PubMed ID: 28673552)
1. Pushing the Limits of Detection of Weak Binding Using Fragment-Based Drug Discovery: Identification of New Cyclophilin Binders.
Georgiou C; McNae I; Wear M; Ioannidis H; Michel J; Walkinshaw M
J Mol Biol; 2017 Aug; 429(16):2556-2570. PubMed ID: 28673552
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies.
Grädler U; Schwarz D; Blaesse M; Leuthner B; Johnson TL; Bernard F; Jiang X; Marx A; Gilardone M; Lemoine H; Roche D; Jorand-Lebrun C
Bioorg Med Chem Lett; 2019 Dec; 29(23):126717. PubMed ID: 31635932
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A.
Steadman VA; Pettit SB; Poullennec KG; Lazarides L; Keats AJ; Dean DK; Stanway SJ; Austin CA; Sanvoisin JA; Watt GM; Fliri HG; Liclican AC; Jin D; Wong MH; Leavitt SA; Lee YJ; Tian Y; Frey CR; Appleby TC; Schmitz U; Jansa P; Mackman RL; Schultz BE
J Med Chem; 2017 Feb; 60(3):1000-1017. PubMed ID: 28075591
[TBL] [Abstract][Full Text] [Related]
4. Experiences in fragment-based lead discovery.
Hubbard RE; Murray JB
Methods Enzymol; 2011; 493():509-31. PubMed ID: 21371604
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cyclosporin A and a set of analogs as inhibitors of a T. cruzi cyclophilin by docking and molecular dynamics.
Carraro R; Iribarne F; Paulino M
J Biomol Struct Dyn; 2016; 34(2):399-413. PubMed ID: 26046477
[TBL] [Abstract][Full Text] [Related]
6. Discovery and Validation of the Binding Poses of Allosteric Fragment Hits to Protein Tyrosine Phosphatase 1b: From Molecular Dynamics Simulations to X-ray Crystallography.
Greisman JB; Willmore L; Yeh CY; Giordanetto F; Shahamadtar S; Nisonoff H; Maragakis P; Shaw DE
J Chem Inf Model; 2023 May; 63(9):2644-2650. PubMed ID: 37086179
[TBL] [Abstract][Full Text] [Related]
7. Algorithms for the automated selection of fragment-like molecules using single-point surface plasmon resonance measurements.
Kreatsoulas C; Narayan K
Anal Biochem; 2010 Jul; 402(2):179-84. PubMed ID: 20371355
[TBL] [Abstract][Full Text] [Related]
8. [Progress in the fragment-based drug discovery].
Ren J; Li J; Shi F; Wang X; He JH; Xu YC; Zhang NX; Xiong B; Shen JK
Yao Xue Xue Bao; 2013 Jan; 48(1):14-24. PubMed ID: 23600136
[TBL] [Abstract][Full Text] [Related]
9. Combining 'dry' co-crystallization and in situ diffraction to facilitate ligand screening by X-ray crystallography.
Gelin M; Delfosse V; Allemand F; Hoh F; Sallaz-Damaz Y; Pirocchi M; Bourguet W; Ferrer JL; Labesse G; Guichou JF
Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1777-87. PubMed ID: 26249358
[TBL] [Abstract][Full Text] [Related]
10. Fragment-based lead discovery and design.
Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D
J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951
[TBL] [Abstract][Full Text] [Related]
11. Discovery of non-peptidic small molecule inhibitors of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction.
Park I; Londhe AM; Lim JW; Park BG; Jung SY; Lee JY; Lim SM; No KT; Lee J; Pae AN
J Comput Aided Mol Des; 2017 Oct; 31(10):929-941. PubMed ID: 28913661
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Characterization of the Binding and Unbinding of Millimolar Drug Fragments with Molecular Dynamics Simulations.
Pan AC; Xu H; Palpant T; Shaw DE
J Chem Theory Comput; 2017 Jul; 13(7):3372-3377. PubMed ID: 28582625
[TBL] [Abstract][Full Text] [Related]
13. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
[TBL] [Abstract][Full Text] [Related]
14. Computational insight into small molecule inhibition of cyclophilins.
Sambasivarao SV; Acevedo O
J Chem Inf Model; 2011 Feb; 51(2):475-82. PubMed ID: 21194235
[TBL] [Abstract][Full Text] [Related]
15. A computationally designed binding mode flip leads to a novel class of potent tri-vector cyclophilin inhibitors.
De Simone A; Georgiou C; Ioannidis H; Gupta AA; Juárez-Jiménez J; Doughty-Shenton D; Blackburn EA; Wear MA; Richards JP; Barlow PN; Carragher N; Walkinshaw MD; Hulme AN; Michel J
Chem Sci; 2019 Jan; 10(2):542-547. PubMed ID: 30746096
[TBL] [Abstract][Full Text] [Related]
16. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
Hennig M; Ruf A; Huber W
Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Kinase Production and Fragment Screening by NMR Spectroscopy.
Han B; Ahn HC
Methods Mol Biol; 2016; 1360():35-46. PubMed ID: 26501900
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery.
Coutard B; Decroly E; Li C; Sharff A; Lescar J; Bricogne G; Barral K
Antiviral Res; 2014 Jun; 106():61-70. PubMed ID: 24704437
[TBL] [Abstract][Full Text] [Related]
19. From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance.
Giannetti AM
Methods Enzymol; 2011; 493():169-218. PubMed ID: 21371592
[TBL] [Abstract][Full Text] [Related]
20. Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
Lange JH; Venhorst J; van Dongen MJ; Frankena J; Bassissi F; de Bruin NM; den Besten C; de Beer SB; Oostenbrink C; Markova N; Kruse CG
Eur J Med Chem; 2011 Oct; 46(10):4808-19. PubMed ID: 21880399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
